US 10668062
Oxabicycloheptanes and oxabicycloheptenes for the treatment of diabetes
granted A61KA61K31/34A61K31/4178
Quick answer
US patent 10668062 (Oxabicycloheptanes and oxabicycloheptenes for the treatment of diabetes) held by Lixte Biotechnology, Inc. expires Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Lixte Biotechnology, Inc.
- Grant date
- Tue Jun 02 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/34, A61K31/4178, A61K31/4525, A61K31/496